<ѻýҕl>MET Inhibitor Rescues Some Targeted Tx Failures in NSCLCѻýҕl> Savolitinib promising in patients with MET-based resistance to EGFR inhibition Apr 01, 2019 video
<ѻýҕl>CAR T-Cell Therapy Active in Solid Tumorsѻýҕl> Preliminary data on safety, efficacy in mesothelioma, sarcomas Mar 31, 2019 video
<ѻýҕl>Aggressive Tx in Oligometastatic NSCLC Tied to Improved OSѻýҕl> Histology, intrathoracic disease burden, and bone metastases may predict outcomes Mar 12, 2019
<ѻýҕl>Liquid Biopsy Matches Tissue for NSCLC Guidanceѻýҕl> Increased mutation detection rate, faster turnaround time Feb 27, 2019
<ѻýҕl>Rapid Heart Rate Tied to Higher Mortality in Cancer Patientsѻýҕl> Unexplained tachycardia linked with threefold increase in risk of death Jan 28, 2019
<ѻýҕl>Cancer Treatment and Arthritis: A Growing Complaintѻýҕl> Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
<ѻýҕl>Increased Risk of Chemo-Associated AML for Nearly All Solid Cancersѻýҕl> Extended beyond 5 years for most types with greater risk seen in young patients Dec 20, 2018
<ѻýҕl>Immunotherapy Combo Flops in Metastatic NSCLCѻýҕl> Durvalumab plus tremelimumab failed to improve survival versus chemotherapy Dec 13, 2018
<ѻýҕl>Highlights from Molecular Targets Symposiuimѻýҕl> Breast cancer gene expression, activity in GI, lung, and limited-mutation tumors Nov 16, 2018
<ѻýҕl>Group of Blood Pressure Drugs Linked to Lung Cancerѻýҕl> 14% higher likelihood in users of ACE inhibitors; causal relationship unproven Oct 25, 2018
<ѻýҕl>Hippocampus-Sparing Radiation a New Option in Brain Mets Patientsѻýҕl> Approach preserved cognitive function, but patient prognosis a key consideration Oct 24, 2018
<ѻýҕl>Aggressive RT, Surgery Doubles OS in NSCLC With Limited Metsѻýҕl> If new drug produced such a response it would make "millions," said expert Oct 22, 2018 video
<ѻýҕl>FDA Rejects Canakinumab in CVD Preventionѻýҕl> CANTOS data not enough to expand indication Oct 19, 2018
<ѻýҕl>SBRT Doubles 5-Year Survival in Oligometastatic Cancersѻýҕl> Most patients in phase II trial had up to three metastatic lesions Oct 17, 2018
<ѻýҕl>Lung Screening Saves Lives, but Who Should Be Screened?ѻýҕl> Experts debate controversial screening issues in meeting "Smackdown" Oct 11, 2018
<ѻýҕl>Lung Cancer Screening Rates Fall Short in VAѻýҕl> Adherence was 77% among those with negative baseline screens Oct 04, 2018
<ѻýҕl>More Evidence that Screening Cuts Lung Cancer Deathsѻýҕl> Significantly lower risk in men and women Sep 26, 2018
<ѻýҕl>Newer ALK Inhibitor Tops Standard in NSCLCѻýҕl> Significant improvement in PFS with brigatinib after short follow-up Sep 26, 2018
<ѻýҕl>Anti-PD-L1 Drug Boosts Survival in Stage III NSCLCѻýҕl> New standard of care for patients with inoperable disease Sep 26, 2018
<ѻýҕl>Add-On Keytruda Boosts OS in Advanced Squamous Lung Cancerѻýҕl> Benefit seen across all subgroups, PD-L1 expression levels Sep 25, 2018
<ѻýҕl>No Survival Benefit with Cranial RT for NSCLCѻýҕl> Better disease-free survival, fewer brain mets Sep 25, 2018
<ѻýҕl>Nothing Good for Older Lung Cancer Patients From Add-On Cisplatinѻýҕl> Two trials show no survival benefit and more toxicity Jul 26, 2018
<ѻýҕl>Surveillance Not Resection Called Best For Subsolid Lung Nodulesѻýҕl> Opacities tied to increase in lung cancers, but never fatal during a decade of follow-up Jul 25, 2018
<ѻýҕl>Keytruda Alone Bests Chemo in Advanced NSCLCѻýҕl> Monotherapy boosts survival in patients with low PD-L1, no EGFR or ALK alterations Jun 04, 2018
<ѻýҕl>Refusing Lung Cancer Treatment: Class Trumps Raceѻýҕl> Wide variation in groups at highest risk of turning down treatment May 25, 2018
<ѻýҕl>Lung Cancer Screening Rates Disappointѻýҕl> Evidence shows benefit for high-risk smokers but few get tested May 17, 2018
<ѻýҕl>'Unsolved Mysteries' on Display at AACRѻýҕl> Large, diverse program reflects rapid pace of advancement Apr 13, 2018
<ѻýҕl>ACS: E-Cigarettes OK for Smoking Cessation ... with Caveatsѻýҕl> Short period of dual use OK, if goal is to quit Feb 22, 2018
<ѻýҕl>Lung Biopsies for Genetic Info Appear Safeѻýҕl> Low rate of complications, no deaths Nov 28, 2017
<ѻýҕl>Weather Not a Factor in Pneumothorax Risk with Lung Biopsyѻýҕl> No relationship seen between complications and atmospheric conditions Nov 27, 2017
<ѻýҕl>Shared Decision-Making Strategies for Lung Ca Screening Get High Marksѻýҕl> Patient satisfaction high with physician-led and web-based approaches Nov 02, 2017
<ѻýҕl>Vince DeVita’s Oncology Opusѻýҕl> Medicine and music share center stage in storied career Jul 26, 2017
<ѻýҕl>New Standard for ALK-Positive NSCLCѻýҕl> Dramatic PFS, CNS benefits with alectinib Jun 06, 2017
<ѻýҕl>Genomic Testing Helps Cancer Patients -- When Results are Usedѻýҕl> Also, liquid biopsy can ID drug-responsive tumors Jun 06, 2017
<ѻýҕl>Dacomitinib Sets PFS Record in Phase III NSCLC Trialѻýҕl> Next-gen EGFR inhibitor wins head-to-head battle with gefitinib, at least for efficacy Jun 06, 2017
<ѻýҕl>Immunotherapy Shows Promise in Tough-to-Treat Mesotheliomaѻýҕl> Outcomes improved with nivolumab alone or with ipilimumab in pretreated patients Jun 05, 2017
<ѻýҕl>Advanced Ca Patients Benefit from Online Symptom Reportsѻýҕl> Patient-reported outcomes tied to increased survival Jun 05, 2017
<ѻýҕl>Novel Agent Shows Antitumor Activity in TRK-Fusion Cancersѻýҕl> Tumor genetics define treatment approach in early-stage trials Jun 04, 2017
<ѻýҕl>Asthma Biologic, Rally Among ATS Highlightsѻýҕl> Attendees to organize on Capitol Hill; will also hear benralizumab phase III results May 17, 2017